Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort descending
2018 R21 RFA-CA-17-010 FU, XIAO-AN UNIVERSITY OF LOUISVILLE A microreactor chip platform for quantitative analysis of unsaturated aldehydes in exhaled breath Active
2022 R21 CA21-003 GIBBS, SUMMER LYNNE OREGON HEALTH & SCIENCE UNIVERSITY A Novel Fluorescence Imaging Platform to Predict Response to Combinatorial Tyrosine Kinase Inhibitors Active
2021 R21 RFA-CA-20-019 SANTORE, MARIA M UNIVERSITY OF MASSACHUSETTS AMHERST Paper-based Breastmilk Collection System for Facile, In-Home Use Active
2020 R21 RFA-CA-19-019 CICERONE, MARCUS T GEORGIA INSTITUTE OF TECHNOLOGY Label-Free Cell-Resolved Metabolomics for Tumor Microscopy Active
2021 R21 RFA-CA-20-017 WILSON, GERALD M UNIVERSITY OF MARYLAND BALTIMORE Suppressing oncogenic RNA regulons using engineered zinc finger ribonucleases Active
2020 R21 RFA-CA-19-019 SEELIG, GEORG UNIVERSITY OF WASHINGTON High-resolution spatial transcriptomics through light patterning Active
2019 R21 RFA-CA-18-002 WARREN, CHRISTOPHER L PROTEOVISTA, LLC SNAP-X: Development of a Mutagenesis Strategy and High Density Protein Array to Comprehensively Display Protein Variants Active
2021 R21 RFA-CA-20-017 ZHANG, FANGLIANG UNIVERSITY OF MIAMI SCHOOL OF MEDICINE Targeted degradation of proteins by affinity peptide conjugated ubiquitin (APCU) Active
2020 R21 RFA-CA-19-019 MARTO, JARROD A DANA-FARBER CANCER INST Tools for DUB Drug Discovery Active
2019 R21 RFA-CA-18-002 KENTSIS, ALEX SLOAN-KETTERING INST CAN RESEARCH Multi-dimensional targeted mass spectrometry technology for pathway-scale functional proteomics Active
2021 R21 RFA-CA-20-017 STILL, AMANDA NICOLE HAYMOND GEORGE MASON UNIVERSITY New Hybrid Molecular Modalities Comprised of DNA-Origami and Interfering Peptides as Inhibitors of Protein-Protein Interactions Active
2020 R33 RFA-CA-19-020 COOKS, ROBERT GRAHAM PURDUE UNIVERSITY Advanced Development of Desorption Electrospray Ionization Mass Spectrometry for Intraoperative Molecular Diagnosis of Brain Cancer using Pathology Biopsies Active
2019 R21 RFA-CA-18-002 YAMAMOTO, KEITH ROBERT UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CasCUT&RUN: An in vivo method to analyze locus-specific protein complexes driving transcription of target genes in cancer Active
2022 R33 CA21-004 NORMAN, THOMAS MAXWELL SLOAN-KETTERING INST CAN RESEARCH Systematic characterization of cancer variants using single-cell functional genomics Active
2021 R21 RFA-CA-20-017 XIAO, HAN RICE UNIVERSITY Development of Bone-Targeting Antibodies for Ewing Sarcoma Using Genetic Code Expansion Active
2020 R33 RFA-CA-19-020 RECHT, MICHAEL PALO ALTO RESEARCH CENTER High-Throughput Screening Platform for Cancer Drug Discovery Active
2019 R21 RFA-CA-18-002 WU, YUN STATE UNIVERSITY OF NEW YORK AT BUFFALO Exosome-Protein-microRNA-OneStop (Exo-PROS) biosensor: a new liquid biopsy for cancer screening and early detection Active
2018 R21 RFA-CA-17-010 ROYZEN, MAKSIM STATE UNIVERSITY OF NEW YORK AT ALBANY Development of Catch and Release Approach for Multi-Drug Local Delivery of Chemotherapies Active
2022 R21 CA21-003 BELCHER, ANGELA M MASSACHUSETTS INSTITUTE OF TECHNOLOGY A cell-cycle induced genetic recorder for simultaneous recovery of cell divisions and lineage Complete
1999 R33 PAR-98-067 CHALMERS, JEFFREY JOHN OHIO STATE UNIVERSITY RAPID RARE CANCER CELL ISOLATION FOR MOLECULAR DIAGNOSIS Complete
2001 R33 PAR-99-102 DABORA, SANDRA L BRIGHAM AND WOMEN'S HOSPITAL MUTANT ANALYSIS OF TSC1 & TSC2 IN TSC RELATED DISORDERS Complete
2004 R21 PAR-01-106 DOVICHI, NORMAN J UNIVERSITY OF WASHINGTON SINGLE CELL PROTEIN FINGERPRINTING - BARRETT'S ESOPHAGUS Complete
2007 R21 RFA-CA-07-015 WANG, NICHOLAS J UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB NANO-SCALE DETECTION OF THE DISEASE PROTEOME Complete
2010 R21 RFA-CA-09-008 BARRETT, MICHAEL T TRANSLATIONAL GENOMICS RESEARCH INST HIGH DEFINITION CLONAL ANALYSES OF ARCHIVAL PANCREATIC ADENOCARCINOMA SAMPLES Complete
2014 R21 RFA-CA-13-001 ZENG, YONG UNIVERSITY OF KANSAS LAWRENCE INTEGRATED MICROFLUIDIC EXOSOME PROFILING FOR EARLY DETECTION OF CANCER Complete
2001 R21 PAR-99-100 FARKAS, DANIEL L UNIVERSITY OF PITTSBURGH AT PITTSBURGH CANCER MOLECULE ANALYSIS BY AOTF MULTISPECTRAL IMAGING Complete
2003 R21 PAR-01-106 WOODS, VIRGIL L UNIVERSITY OF CALIFORNIA SAN DIEGO ENHANCED CRYSTALLOGRAPHY OF CANCER-IMPLICATED PROTEINS Complete
2006 R43 RFA-CA-06-005 MOON, JOHN A ILLUMINA, INC. MICROFLUIDIC CAPILLARY ASSAY UTILIZING HOLOGRAPHICALLY * Complete
2009 R21 RFA-CA-08-007 SODERLING, SCOTT H. DUKE UNIVERSITY MAPPING THE ARCHITECTURE OF CANCER SIGNALING PATHWAYS Complete
2013 R21 RFA-CA-13-001 WANG, ANDREW ZHUANG UNIV OF NORTH CAROLINA CHAPEL HILL DEVELOPMENT OF 3D ORGAN-SPECIFIC MODELS OF COLORECTAL CANCER METASTASIS Complete
2016 R21 RFA-CA-15-004 JAHNKE, FRANK SONATA BIOSCIENCES, INC. A NEW SAMPLE PREPARATION METHOD TO DELVE DEEPER INTO THE PROTEOME Complete
2000 R33 PAR-98-067 TOLIAS, PETER P PUBLIC HEALTH RESEARCH INSTITUTE FUNCTIONAL CLONING OF DNA AND RNA BINDING PROTEINS Complete
2002 R33 PAR-99-102 ALLBRITTON, NANCY L UNIVERSITY OF CALIFORNIA IRVINE PROFILING RAS ACTIVATED SIGNAL TRANSDUCTION PATHWAYS Complete
2006 R21 RFA-CA-06-002 LARGAESPADA, DAVID ANDREW UNIVERSITY OF MINNESOTA TWIN CITIES TRANSPOSON-BASED SOMATIC MUTAGENESIS/PROSTATE CANCER GENETICS Complete
2008 R43 RFA-CA-07-041 MATHEW, ANU MESO SCALE DIAGNOSTICS, LLC MULTIPLEXED BIOMARKER PANELS FOR EARLY DETECTION OF PROSTATE CANCER Complete
2011 R43 RFA-CA-10-013 RUAN, BIAO POTOMAC AFFINITY PROTEINS, LLC PROTEASE CHAIN REACTIONS FOR MOLECULAR ANALYSIS OF CANCER MARKERS Complete
2015 R43 PAR-13-327 JIANG, LI A'AS, INC. KS-DETECT: A SOLAR-POWERED AND SMARTPHONE INTEGRATED INSTRUMENT FOR POINT-OF-CARE DIAGNOSIS OF KAPOSI'S SARCOMA Complete
2000 R21 PAR-98-067 SHERRY, A. DEAN UNIVERSITY OF TEXAS DALLAS MRI AGENTS SENSITIVE TO BIOLOGICAL INDICATORS OF NEOPLAS Complete
2002 R21 PAR-01-106 SESHI, BEERELLI LA BIOMED RES INST/ HARBOR UCLA MED CTR FUNCTIONAL PROTEOMICS OF LEUKEMIC MARROW STROMAL CELLS Complete
2005 R21 RFA-CA-05-002 CLAFFEY, KEVIN P. UNIVERSITY OF CONNECTICUT SCH OF MED/DNT IDENTIFICATION OF IMMUNE SELECTED BREAST CANCER ANTIGENS Complete
2008 R21 RFA-CA-07-033 SZMACINSKI, HENRYK UNIVERSITY OF MARYLAND BALTIMORE TIME-RESOLVED FLUOROMETRIC METHOD FOR ASSAY OF MULTIPLE BIOMARKERS Complete
2011 R21 RFA-CA-10-003 BLAIR, SARAH L UNIVERSITY OF CALIFORNIA SAN DIEGO NON-CIRCULATING MICROPARTICLES FOR IMPROVED LOCALIZATION AND RESECTION CANCER Complete
2015 R21 RFA-CA-14-003 HAYDEN, MELANIE STANFORD UNIVERSITY CELL-FREE TUMOR DNA IN CEREBRAL SPINAL FLUID DECODES TUMORS OF THE CENTRAL NERVOUS SYSTEM Complete
2015 R21 RFA-CA-14-003 LABAER, JOSHUA ARIZONA STATE UNIVERSITY-TEMPE CAMPUS MULTIPLEXED IN SOLUTION PROTEIN ARRAY (MISPA) FOR IDENTIFYING NOVEL PROTEIN INTERACTIONS IN CANCER AND FOR EARLY DETECTION OF IMMUNE RESPONSES IN PATHOGEN-INDUCED CANCERS Complete
2022 R33 CA21-004 DRAKE, RICHARD R MEDICAL UNIVERSITY OF SOUTH CAROLINA Targeted Isolation and Identification of Sialylated Glycoproteins in Cancer Tissues, Cells and Biofluids Complete
1999 R33 PAR-98-067 MCCLELLAND, MICHAEL SIDNEY KIMMEL CANCER CENTER REDUCED COMPLEXITY CDNA PROBES Complete
2001 R33 PAR-99-102 WEIER, HEINZ-ULRICH G UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB SPECTRAL IMAGING FOR PHENOTYPE ANALYSIS OF CANCER CELLS Complete
2004 R21 PAR-01-106 SCHROEDER, JANE CLOWNEY UNIVERSITY OF NORTH CAROLINA CHAPEL HILL EPIDEMIOLOGY OF ATYPICAL EPSTEIN-BARR VIRUS IN LYMPHOMA Complete
2007 R21 RFA-CA-07-017 XU, BAOGANG JONATHAN VANDERBILT UNIVERSITY MED CTR IDENTIFICATION OF BREAST TUMOR SECRETOME CHANGES THROUGHOUT TUMOR PROGRESSION Complete
2010 R21 RFA-CA-09-008 RIETHMAN, HAROLD WISTAR INSTITUTE TECHNOLOGY FOR DETECTION AND QUANTITATION OF TELOMERIC DNA ABERRATIONS IN CANCER Complete

Pages